HIV/AIDS drug price not the “rate-limiting factor” it was once thought Comment 30 January 2013 Pages: 3 - 3
Cardiovascular drug use reduced after bariatric surgery for obesity Clinical study 30 January 2013 Pages: 4 - 4
Tenecteplase plus enoxaparin “economically attractive” in MI Clinical study 30 January 2013 Pages: 4 - 4
Which atypical antipsychotic most costly in bipolar disorder? Clinical study 30 January 2013 Pages: 4 - 4
Treatment of dyslipidaemia inadequate in actual medical practice Clinical study 30 January 2013 Pages: 5 - 5
Improving persistence with bisphosphonate therapy worth it Clinical study 30 January 2013 Pages: 7 - 7
PEG IFN-α-2a + ribavirin confers significant benefit for little extra cost Clinical study 30 January 2013 Pages: 7 - 7
Fine line between benefit and harm conferred by prophylactic aspirin Clinical study 30 January 2013 Pages: 8 - 8
Patient risk dictates value of NSAID therapy in arthritis Clinical study 30 January 2013 Pages: 8 - 8
Factors associated with celecoxib, rofecoxib use in the US Clinical study 30 January 2013 Pages: 9 - 9
Intervention reduces inappropriate medicine use among elderly Clinical study 30 January 2013 Pages: 10 - 10
Outpatient-based DOT reduces treatment cost of MDR tuberculosis Clinical study 30 January 2013 Pages: 10 - 10
Better ADHD treatment for Hispanic/Latino children needed Media release 30 January 2013 Pages: 11 - 11
Efalizumab and etanercept cost-effective choices in psoriasis Clinical study 30 January 2013 Pages: 11 - 11
Amifostine: potential to alleviate oesophagitis, QOL in NSCLC Clinical study 30 January 2013 Pages: 12 - 12
Cilansetron beneficial in IBS with diarrhoea predominance Clinical study 30 January 2013 Pages: 13 - 13
QOL effect of chemotherapy-related toxicity: news from ASCO Clinical study 30 January 2013 Pages: 13 - 13
Somatropin the ticket to better QOL in GH-deficient cancer survivors Clinical study 30 January 2013 Pages: 13 - 13
Stem cell research bill passes US House, but uphill battle ahead News item 30 January 2013 Pages: 15 - 15